(5S,7R,8R,9R,10S)-(-)-7,8-seco-7, 8-oxacassa-13,15-dien-7-ol - Compound Card

(5S,7R,8R,9R,10S)-(-)-7,8-seco-7, 8-oxacassa-13,15-dien-7-ol

Select a section from the left sidebar

(5S,7R,8R,9R,10S)-(-)-7,8-seco-7, 8-oxacassa-13,15-dien-7-ol

Structure
Zoomed Structure
  • Family: Plantae - Mimosaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Diterpene
Canonical Smiles C=CC1=C(C)[C@H]2[C@H](CC1)[C@@]1(C)CCCC([C@@H]1C[C@@H](O2)O)(C)C
InChI InChI=1S/C20H32O2/c1-6-14-8-9-15-18(13(14)2)22-17(21)12-16-19(3,4)10-7-11-20(15,16)5/h6,15-18,21H,1,7-12H2,2-5H3/t15-,16-,17+,18-,20+/m0/s1
InChIKey LYHHJTUWLMOJRZ-HBWRTXEVSA-N
Formula C20H32O2
HBA 2
HBD 1
MW 304.47
Rotatable Bonds 1
TPSA 29.46
LogP 4.84
Number Rings 3
Number Aromatic Rings 0
Heavy Atom Count 22
Formal Charge 0
Fraction CSP3 0.8
Exact Mass 304.24
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Acacia nilotica Mimosaceae Plantae 138033

Showing of synonyms

  • Anyam JV, Daikwo PE, et al. (2021). Two New Antiprotozoal Diterpenes From the Roots of Acacia nilotica. Frontiers in Chemistry,2021,9. [View]
Pubchem: 70698169
Chebi: 69397
Nmrshiftdb2: 70049320
Metabolights: MTBLC69397

No compound-protein relationship available.

Structure

SMILES: C1CC=CC2OCCC(C3C12)CCCC3

Level: 0

Mol. Weight: 304.47 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.67
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.35
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.81

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.89
Plasma Protein Binding
61.24
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Inhibitor
CYP 2C19 Substrate
Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
17.32
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
0.91
Biodegradation
Safe
Carcinogenesis
Toxic
Crustacean
Toxic
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-0.83
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
4.93
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
0.93
Rat (Acute)
2.38
Rat (Chronic Oral)
1.52
Fathead Minnow
3.92
Respiratory Disease
Toxic
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
347.48
Hydration Free Energy
-3.29
Log(D) at pH=7.4
4.47
Log(P)
5.37
Log S
-5.06
Log(Vapor Pressure)
-5.75
Melting Point
125.26
pKa Acid
11.99
pKa Basic
7.09
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Nuclear receptor subfamily 1 group I member 2 O75469 NR1I2_HUMAN Homo sapiens 3 0.7319
Lactoylglutathione lyase Q9CPU0 LGUL_MOUSE Mus musculus 2 0.7279

Download SDF